Last reviewed · How we verify
NCT05880381: AViR
Virtual Reality for Coping With Involuntary Early Pregnancy Loss
NA trial testing Virtual Reality Group in Early Pregnancy Loss in 20 participants. Currently enrolling.
30 June 2025
Quick facts
| Lead sponsor | Universidade da Madeira |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 20 |
| Start date | 1 May 2023 |
| Primary completion | 30 June 2025 |
| Estimated completion | 30 September 2025 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Virtual Reality Group
- Control Group — full drug profile →
Conditions studied
- Early Pregnancy Loss — all drugs for Early Pregnancy Loss →
Sponsor
Universidade da Madeira
Who can join
18 and older, female only, with Early Pregnancy Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to provide psychological support to women that experienced an Early Pregnancy Loss (when the loss occurs until the 20 weeks of gestation) using an innovative Virtual Reality prototype and compare the presence and evolution of psychological distress symptoms pre and post-intervention. The main goals of this study are: 1. Evaluate the impact of the proposed VR paradigm in women who suffered a gestational loss in the first 20 weeks of gestation, compared to a control group that follows the usual standard care; 2. Evaluate the usability, user experience, and acceptance of the proposed approach. Participants in the VR group will have an intervention program lasting four weeks, with 3 weekly sessions of 45-60 minutes, using the developed prototype.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05880381
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Virtual Reality Group
Trials testing the same drug.
- NCT06443060 — The Effect of Virtual Reality and Buzzy Application on Pain, Fear and Anxiety During Prick Test in Children · NA · not yet recruiting
- NCT07050095 — Anxiolytic Effect of Virtual Reality Immersion Versus Midazolam Premedication in Patients Undergoing Dacryocystorhinosto · NA · recruiting
- NCT06895330 — Effects of Virtual Reality and Helfer Skin Tap During Vaccination · NA · not yet recruiting
- NCT06961097 — The Effect of Virtual Reality on Women Undergoing Endometrial Biopsy · NA · recruiting
- NCT06558292 — The Effect of a Pre-Clinical Practice Simulation Using Virtual Reality Stress and Anxiety Levels · NA · enrolling by invitation
Other recruiting trials for Early Pregnancy Loss
Currently open trials in the same condition.
- NCT06647849 — Interest of Simulation Training on the Announcement of Early Pregnancy Loss on the Psychological Impact of the Patients · NA · recruiting
- NCT06452719 — Letrozole and Misoprostol for Early Pregnancy Loss Management · Phase 2 · recruiting
- NCT04595760 — Factors Influencing Fertility or Pregnancy Health · active not recruiting
Other Universidade da Madeira trials
Trials by the same sponsor.
- NCT05929287 — Comparing Personalized and Adaptive Cognitive Training Methods Following Stroke · NA · completed
- NCT05316766 — Multi-user Touch Surfaces for Promoting Social Participation and Self-efficacy in Upper-limb Stroke Rehabilitation · NA · completed
- NCT05100849 — Kinect-based Versus Tablet-based Cognitive Training: a Pilot Study With Psychiatric Patients · NA · completed
- NCT05038579 — Clinical Validation of a Cognitive Stimulation Platform for Individuals With Dementia - Musiquence · NA · completed
- NCT04376138 — Longitudinal Validation of Neurofeedback in Stroke Motor Rehabilitation Through Brain Imaging · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05880381 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade da Madeira
- Last refreshed: 25 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05880381.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing